Johnson & Johnson Sues Samsung
This is a Stelara news story, published by Yahoo Finance, that relates primarily to Samsung Bioepis' news.
Stelara news
For more Stelara news, you can click here:
more Stelara newsSamsung Bioepis' news
For more Samsung Bioepis' news, you can click here:
more Samsung Bioepis' newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Samsung Bioepis. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Teva Pharmaceuticals news, biosimilar Pyzchiva news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
biosimilarReuters
•Health
Health
J&J sues Samsung Bioepis over contract breach for Stelara biosimilar

79% Informative
J&J said it is seeking a preliminary injunction for Samsung Bioepis' close copy of Stelara .
The company, along with partner Sandoz , said earlier on Monday that its biosimilar Pyzchiva is now available in the United States .
Teva Pharmaceuticals and Alvotech last Friday launched Selarsdi , a biosimilar to the autoimmune drug.
At least six close copies are expected to launch in the U.S. this year .
VR Score
85
Informative language
88
Neutral language
80
Article tone
formal
Language
English
Language complexity
73
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
Small business owner?